Flavia Borellini - 20 Jun 2024 Form 4/A Insider Report for Revolution Medicines, Inc. (RVMD)

Role
Director
Signature
/s/ Jack Anders, as Attorney-in-fact for Flavia Borellini
Issuer symbol
RVMD
Transactions as of
20 Jun 2024
Net transactions value
$0
Form type
4/A
Filing time
28 Jun 2024, 17:08:29 UTC
Date Of Original Report
24 Jun 2024
Previous filing
09 Jun 2023
Next filing
30 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Award $0 +4,248 +24% $0.000000 21,882 20 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Award $0 +15,955 $0.000000 15,955 20 Jun 2024 Common Stock 15,955 $37.54 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 4,851 restricted stock units ("RSUs").
F2 Shares subject to the Stock Option shall vest in full on the earlier of (i) the first anniversary of June 20, 2024 or (ii) immediately prior to the Issuer's annual meeting of stockholders following the date of grant, subject to the Reporting Person continuing in service through the vesting date.

Remarks:

On June 24, 2024, the Reporting Person filed a Form 4 that inadvertently reported incorrect amounts for the RSU and Stock Option awards granted to the Reporting Person on June 20, 2024. The correct amounts and footnote information are reflected in this amendment.